FTC
Illumina to Divest Grail After US Appeals Court Sends Case Back to FTC
The sequencing instrument maker said it plans to finalize terms for a sale or IPO by the end of the second quarter of 2024.
Illumina Appeals FTC's Order to Divest Grail, Cites Government Overreach
In its petitioner's brief, Illumina and Grail called the FTC an "unconstitutional agency" and ask the court to revers the commission's decision.
Court Fast-Tracks Illumina Appeal of FTC Ruling as Voting Starts in Contested Director Election
The firm's annual meeting will be held virtually on May 25, but voting has already commenced for the battle over three board seats, including the one held by the CEO.
US Federal Trade Commission Orders Illumina to Unwind Grail Acquisition
Illumina plans to appeal the decision, seeking a resolution by late 2023 or early 2024, but now faces a third source of pressure to divest Grail.
EU to Disallow Illumina's Grail Purchase
Separately, the US Federal Trade Commission said it will appeal an administrative law judge's initial decision in an antitrust case that was favorable to Illumina.
Dec 30, 2021
Top 10 Articles on GenomeWeb in 2021
Aug 19, 2021
Mar 30, 2021
FTC Moves to Block Illumina's $8B Grail Acquisition
Jan 8, 2013
Illumina Withdraws Complete Genomics Bid
Sep 12, 2011